Nav: Home

How effective and safe is hormone treatment in pregnant women with mild thyroid problems?

January 25, 2017

Thyroid hormone treatment is associated with a decreased risk of pregnancy loss among women with mild thyroid problems, finds a study published by The BMJ today.

However, treatment was also linked with an increased risk of complications such as preterm delivery, gestational diabetes, and pre-eclampsia.

A mildly underactive thyroid gland (known as subclinical hypothyroidism or mild thyroid failure) causes levels of thyroid stimulating hormone (TSH) in the bloodstream to become slightly elevated.

It is estimated to affect up to 15% of pregnancies in the US and 14% in Europe. Some studies have suggested a link with adverse pregnancy outcomes, but there is insufficient evidence to be sure.

However, current guidelines recommend thyroid hormone treatment for pregnant women with subclinical hypothyroidism

So a team of Mayo Clinic researchers led by Spyridoula Maraka, Research Collaborator at Mayo Clinic and Assistant Professor of Medicine at the University of Arkansas for Medical Sciences and the Central Arkansas Veterans Health Care System in the USA, set out to estimate the potential effectiveness and safety of thyroid hormone treatment among pregnant women with subclinical hypothyroidism

Using a large US database, they analysed data from 5,405 pregnant women with subclinical hypothyroidism, defined as untreated TSH levels of 2.5 to 10 mIU/L.

Women treated with thyroid hormone were compared with untreated women for risk of pregnancy loss and other pregnancy related adverse outcomes.

Overall, only 16% of women in the study received thyroid hormone treatment. Compared with untreated women, treated women had a lower risk of pregnancy loss but a higher risk of preterm delivery, gestational diabetes, and pre-eclampsia.

Furthermore, the associated benefit of thyroid hormone treatment on pregnancy loss was seen only among women with TSH levels of 4.1 to 10 mIU/L before treatment (not those with levels of 2.5 to 4 mIU/L).

"On the basis of our findings, continuing to offer thyroid hormone treatment to decrease the risk of pregnancy loss in pregnant women with TSH concentrations of 4.1-10.0 mIU/L is reasonable," say the authors.

However, they add that, given the smaller magnitude of the relationship in the group with TSH concentrations of 2.5-4.0 mIU/L, and in light of the possible increased risk of other adverse events, "treatment may need to be withheld in this group and guidelines may need to be revised."

This is an observational study, so firm conclusions about cause and effect cannot be drawn. Nonetheless, the authors say their results "could facilitate an informed conversation between patients and clinicians about starting thyroid hormone treatment."
Research: Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment

About BMJ

BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. For a full list of BMJ products and services, please visit


Related Gestational Diabetes Articles:

Large meta-analysis links IVF to higher gestational diabetes risk
Women who give birth to singleton babies following assisted reproductive technologies including vitro fertilisation (IVF) are at greater risk of developing gestational diabetes than those who conceive naturally, according to a meta-analysis involving over almost 2 million singleton pregnancies.
Mediterranean diet during pregnancy reduces gestational diabetes and weight gain
A simple Mediterranean-style diet in pregnancy does not reduce the overall risk of adverse maternal and offspring complications, but has the potential to reduce weight gain in pregnancy and the risk of gestational diabetes, according to a clinical trial led by Queen Mary University of London and the University of Warwick.
Study: PFAS move from mom to fetus at higher rate in women with gestational diabetes
A University of Massachusetts Amherst environmental epidemiologist studying the presence of PFAS compounds in new mothers and their babies found that women with gestational diabetes had a 'significantly higher' rate of transferring the synthetic chemicals to their fetus.
Gestational diabetes in India and Sweden
Indian women are younger and leaner than Swedish women when they develop gestational diabetes, a new study from Lund University shows.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
More Gestational Diabetes News and Gestational Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...